There is room for efficiency gains and improvement of the quality of relative effectiveness assessments in Europe, I hope my research can contribute towards this.
Education and experience:
MSc Sarah Kleijnen is a professional PhD candidate at the division of Pharmacoepidemiology & Clinical Pharmacology and advisor at the Dutch National Healthcare Institute (Zorginstituut Nederland). She was trained as biologist and health economist. Her research focuses on the assessment of pharmaceuticals for reimbursement decision making. Sarah started her working career as a consultant for pricing and reimbursement issues of medical technologies. In 2007, she started as an assessor of hospital interventions at the Dutch National Healthcare Institute. From 2009 until 2014 she was project coordinator of Workpackage 5 of the European Network for Health Technology Assessment (EUnetHTA) on rapid relative effectiveness assessments.
Former PhD project:
Harmonisation of relative effectiveness assessment of pharmaceuticals in Europe.